JP2005506300A5 - - Google Patents

Download PDF

Info

Publication number
JP2005506300A5
JP2005506300A5 JP2002578411A JP2002578411A JP2005506300A5 JP 2005506300 A5 JP2005506300 A5 JP 2005506300A5 JP 2002578411 A JP2002578411 A JP 2002578411A JP 2002578411 A JP2002578411 A JP 2002578411A JP 2005506300 A5 JP2005506300 A5 JP 2005506300A5
Authority
JP
Japan
Prior art keywords
seq
peptide
residue
cells
leucine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002578411A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005506300A (ja
JP4310107B2 (ja
Filing date
Publication date
Priority claimed from US09/820,053 external-priority patent/US6875744B2/en
Application filed filed Critical
Priority claimed from PCT/US2002/009534 external-priority patent/WO2002079408A2/en
Publication of JP2005506300A publication Critical patent/JP2005506300A/ja
Publication of JP2005506300A5 publication Critical patent/JP2005506300A5/ja
Application granted granted Critical
Publication of JP4310107B2 publication Critical patent/JP4310107B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002578411A 2001-03-28 2002-03-28 生物活性を有する短ペプチド及び該ペプチドの使用方法 Expired - Lifetime JP4310107B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27950501P 2001-03-28 2001-03-28
US09/820,053 US6875744B2 (en) 2001-03-28 2001-03-28 Short bioactive peptides
PCT/US2002/009534 WO2002079408A2 (en) 2001-03-28 2002-03-28 Short bioactive peptides and methods for their use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009004309A Division JP4484941B2 (ja) 2001-03-28 2009-01-13 生物活性を有する短ペプチド及び該ペプチドの使用方法

Publications (3)

Publication Number Publication Date
JP2005506300A JP2005506300A (ja) 2005-03-03
JP2005506300A5 true JP2005506300A5 (enExample) 2005-12-22
JP4310107B2 JP4310107B2 (ja) 2009-08-05

Family

ID=26959709

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002578411A Expired - Lifetime JP4310107B2 (ja) 2001-03-28 2002-03-28 生物活性を有する短ペプチド及び該ペプチドの使用方法
JP2009004309A Expired - Lifetime JP4484941B2 (ja) 2001-03-28 2009-01-13 生物活性を有する短ペプチド及び該ペプチドの使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009004309A Expired - Lifetime JP4484941B2 (ja) 2001-03-28 2009-01-13 生物活性を有する短ペプチド及び該ペプチドの使用方法

Country Status (8)

Country Link
US (1) US7381704B2 (enExample)
EP (2) EP2105141B1 (enExample)
JP (2) JP4310107B2 (enExample)
KR (1) KR100891157B1 (enExample)
AU (1) AU2002255952A1 (enExample)
CA (1) CA2441562C (enExample)
ES (1) ES2389285T3 (enExample)
WO (1) WO2002079408A2 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004091495A2 (en) * 2003-04-09 2004-10-28 University Of Utah Research Foundation Compositions and methods related to production of erythropoietin
JP2005281225A (ja) * 2004-03-30 2005-10-13 Japan Science & Technology Agency 新規塩基性抗菌ペプチド及びその利用
KR20080042843A (ko) * 2005-07-27 2008-05-15 나스텍 파마수티컬 컴퍼니 인코포레이티드 치료제의 점막 전달 향상을 위한 밀착 연접 조절 펩티드성분
US7601361B2 (en) * 2005-10-03 2009-10-13 E. I. Du Pont De Nemours And Company Process for providing antimicrobial surfaces
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
CA2822302A1 (en) 2006-02-13 2007-08-23 Alethia Biotherapeutics Inc. Methods of impairing osteoclast differentiation
KR101552453B1 (ko) * 2006-06-01 2015-09-11 데라퓨틱 펩타이즈, 인코포레이션 중합성 생계면활성제
RU2441877C2 (ru) 2006-06-13 2012-02-10 Хеликс Байомедикс Инк. Тетрапептид, композиция (варианты) и способ стимуляции продукции коллагена фибробластом
KR100742982B1 (ko) * 2006-06-22 2007-07-26 케이맥(주) 초점 타원계측기
US7696174B2 (en) * 2007-01-05 2010-04-13 Helix Biomedix, Inc. Short bio-active peptides for cellular and immunological modulation
EP2152726B8 (en) * 2007-05-01 2015-02-18 Fundação de Amparo à Pesquisa do Estado de São Paulo - FAPESP Analgesic compounds
CN101855235B (zh) 2007-10-29 2013-04-24 赫里克斯生物医疗公司 保护性皮肤护理四肽
GB0803352D0 (en) * 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
EP2168591A1 (en) * 2008-09-24 2010-03-31 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Antimicrobial peptides
US20120270770A1 (en) * 2010-08-03 2012-10-25 Jesse Michael Jaynes Anti-angiogenic peptides and their uses
WO2014012165A1 (en) 2012-07-19 2014-01-23 Alethia Biotherapeutics Inc. Anti-siglec-15 antibodies
ITBS20120126A1 (it) * 2012-08-01 2014-02-02 Paoli Ambrosi Gianfranco De Composizione antibatterica per uso topico
JP2016518352A (ja) * 2013-04-09 2016-06-23 モヘイ エルディン エラウダン，カーレド 悪性腫瘍のコントロールにおける単剤治療としての新規ペプチド
GB201319620D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy
KR102478073B1 (ko) 2014-10-14 2022-12-16 립타이드 바이오사이언스, 인코포레이티드 항-염증 특성을 갖는 펩타이드
CN105061562B (zh) * 2015-09-16 2018-01-12 山东电力中心医院 一种具有抗肺癌作用的寡肽及其应用
US9439917B1 (en) * 2015-12-28 2016-09-13 Shetal Amit Shah Anti-blepharitis compositions and their use
JP7105696B2 (ja) 2016-02-29 2022-07-25 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド 感染症を治療するステープル化細胞内ターゲティング抗微生物ペプチド
JP7305614B2 (ja) 2017-07-19 2023-07-10 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド 抗生物質耐性細菌感染症の処置のための安定化抗菌ペプチド
WO2019210377A1 (en) * 2018-04-30 2019-11-07 L'oreal Bioactive peptides having high binding affinity to human muscular nicotinic acetylcholine receptor
FR3099060B1 (fr) * 2019-07-26 2022-01-14 Bionuclei Complexe hybride mineral et organique et son utilisation pour le maintien de l’equilibre microbiologique de la peau et/ou d’une composition cosmetique et/ou dermopharmaceutique
WO2025122089A1 (en) * 2023-12-06 2025-06-12 Karadeni̇z Tekni̇k Uni̇versi̇tesi̇ Teknoloji̇ Transferi̇ Uygulama Ve Arasti̇rma Merkezi̇ Development of a novel chitosan conjugated antimicrobial peptide as an alternative to antibiotics
WO2025157595A2 (en) * 2024-01-25 2025-07-31 Lipotrue, S.L. Peptides and cosmetic compositions for use in the treatment of acne and its related skin conditions

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4355104A (en) 1980-06-17 1982-10-19 Kabigen Ab Bacteriolytic proteins
US4520016A (en) 1980-06-17 1985-05-28 Kabigen Ab Bacteriolytic proteins
US5861478A (en) 1987-07-06 1999-01-19 Helix Biomedix, Inc. Lytic peptides
CA1327311C (en) * 1987-07-06 1994-03-01 Jesse M. Jaynes Therapeutic antimicrobial polypeptides, their use and methods for preparation
KR970006154B1 (ko) * 1987-07-06 1997-04-24 루이지아나 스테이트 유니버시티 아그리컬춰럴 앤드 메카니칼 컬리지 용해성 펩티드에 의한 진핵 병원체와 신생물의 억제 및 섬유아세포와 임파구의 자극
WO1990012866A1 (en) * 1989-04-10 1990-11-01 Louisiana State University And Agricultural And Mechanical College Lytic peptides, use for growth, infection and cancer
WO1992017195A1 (en) * 1991-04-08 1992-10-15 Magainin Pharmaceuticals, Inc. Novel peptide compositions and uses therefor
US5561107A (en) 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
US5955573A (en) * 1993-06-04 1999-09-21 Demegen, Inc. Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same
AU7050294A (en) * 1993-06-04 1995-01-03 Demeter Biotechnologies, Ltd. Method of treating pulmonary disease states with non-naturally occurring amphipathic peptides
AU1086595A (en) * 1993-11-08 1995-05-29 Demeter Biotechnologies, Ltd. Methylated lysine-rich lytic peptides and method of making same by reductive alkylation
US5789542A (en) * 1994-04-22 1998-08-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Amphipathic peptides
IL114697A0 (en) * 1994-07-22 1995-11-27 Demeter Biotech Ltd Polypeptides comprising ubiquitin-lytic peptide fusion protein products deriving therefrom their preparation and use
EP0866805A1 (en) * 1995-12-12 1998-09-30 Karolinska Innovations AB PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b)
US6566334B1 (en) * 1997-02-06 2003-05-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Short amphipathic peptides with activity against bacteria and intracellular pathogens
US6635740B1 (en) * 1997-03-27 2003-10-21 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Ligand/lytic peptide compositions and methods of use
US6958212B1 (en) * 1999-02-01 2005-10-25 Eidgenossische Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
WO2001049834A2 (en) 2000-01-06 2001-07-12 Monsanto Technology Llc Preparation of deallergenized patatin proteins and patatin permutein proteins

Similar Documents

Publication Publication Date Title
JP2005506300A5 (enExample)
Patrulea et al. An update on antimicrobial peptides (AMPs) and their delivery strategies for wound infections
Dostert et al. Antibiofilm peptides: overcoming biofilm-related treatment failure
US11590164B2 (en) Topical antimicrobial formulations containing monovalent copper ions and systems for generating monovalent copper ions
Gawande et al. Antibiofilm and antimicrobial efficacy of DispersinB®-KSL-W peptide-based wound gel against chronic wound infection associated bacteria
Smith Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
AU760870B2 (en) Method and composition for the treatment of epidermal irritations and infections
JP2017525676A5 (enExample)
KR100891157B1 (ko) 짧은 생물활성 펩티드 및 그것들의 사용 방법
JP2015515960A (ja) 局所非水性医薬製剤
JP6964577B2 (ja) 抗菌性ペプチド及びその使用方法
CA2468916A1 (en) A stable oxaliplatin solution formulation
JP2002526407A5 (enExample)
JP2009525284A (ja) バイオフィルム関連感染を処置するためのガリウムの使用
Wernicki et al. Antimicrobial properties of gold, silver, copper and platinum nanoparticles against selected microorganisms isolated from cases of mastitis in cattle
AU4069997A (en) Enhancement of antimicrobial peptide activity by metal ions
JP2018513186A5 (enExample)
JP2003508416A (ja) 金属含有組成物、その製法および用法
Griffith et al. Anti-microbiological and anti-infective activities of silver
WO2002102311A3 (en) Nanoparticles for treating targeted tissues and cells
EP3681468B1 (en) Antimicrobial composition
JP2008508265A5 (enExample)
RU2007107390A (ru) Противомикробные пептиды
AU2001289641A1 (en) Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses
RU2001126056A (ru) Применение (R)-арилпропионовых кислот для получения лекарственных средств для лечения заболеваний людей и животных, на которые можно оказывать терапевтическое воздействие путем ингибирования активации NF-кВ